Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden · Delayed Price · Currency is SEK 5.95
+0.29 (5.11%)
Mar 20, 2026, 5:29 PM CET
-68.49% (1Y)
| Market Cap | 122.56M -49.7% |
| Revenue (ttm) | 152.35M -23.3% |
| Net Income | 127.24M |
| EPS | 10.45 |
| Shares Out | 20.61M |
| PE Ratio | 0.96 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 28,976 |
| Average Volume | 68,536 |
| Open | 5.60 |
| Previous Close | 5.66 |
| Day's Range | 5.42 - 5.95 |
| 52-Week Range | 5.42 - 38.25 |
| Beta | 0.66 |
| RSI | 32.61 |
| Earnings Date | Feb 20, 2026 |